TY - JOUR
T1 - Human papillomavirus (HPV) vaccine utilization among adults (18–29 years), BRFSS 2015
AU - Wiener, R. Constance
AU - Findley, Patricia A.
AU - Shen, Chan
AU - Dwibedi, Nilanjana
AU - Sambamoorthi, Usha
N1 - Funding Information:
Research reported in this manuscript was supported by the National Institute of General Medical Sciences of the National Institutes of Health under Award Number 5U54GM104942-04 . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2020 Elsevier Ltd
PY - 2020/7/14
Y1 - 2020/7/14
N2 - Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.
AB - Human papillomavirus (HPV) vaccination acceptance is hampered by fears and conflicting attitudes about the need for and safety of vaccine. There are also ethical dilemmas associated with vaccinating adolescents for a sexually transmitted disease despite future cancer risk. The purpose of this research was to determine HPV vaccination acceptance/hesitancy among young adults. Behavioral Risk Factor Surveillance System 2015 data were used. During 2015, 83.1% of adults ages 25–29 years did not receive any HPV vaccination; the UOR was 3.47; 95% CI = 2.11, 5.70) compared to adults 18–24 years. There is a need to accelerate public health messaging/campaigns to increase HPV vaccination rates.
UR - http://www.scopus.com/inward/record.url?scp=85086677624&partnerID=8YFLogxK
U2 - 10.1016/j.vaccine.2020.05.056
DO - 10.1016/j.vaccine.2020.05.056
M3 - Article
C2 - 32565345
AN - SCOPUS:85086677624
SN - 0264-410X
VL - 38
SP - 5119
EP - 5122
JO - Vaccine
JF - Vaccine
IS - 33
ER -